These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37484098)

  • 1. Alzheimer's disease: a continuum with visual involvements.
    Elvira-Hurtado L; López-Cuenca I; de Hoz R; Salas M; Sánchez-Puebla L; Ramírez-Toraño F; Matamoros JA; Fernández-Albarral JA; Rojas P; Alfonsín S; Delgado-Losada ML; Ramírez AI; Salazar JJ; Maestu F; Gil P; Ramírez JM; Salobrar-García E
    Front Psychol; 2023; 14():1124830. PubMed ID: 37484098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in visual function and retinal structure in the progression of Alzheimer's disease.
    Salobrar-García E; de Hoz R; Ramírez AI; López-Cuenca I; Rojas P; Vazirani R; Amarante C; Yubero R; Gil P; Pinazo-Durán MD; Salazar JJ; Ramírez JM
    PLoS One; 2019; 14(8):e0220535. PubMed ID: 31415594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verification of the association between cognitive decline and olfactory dysfunction using a DEmentia screening kit in subjects with Alzheimer's dementia, mild cognitive impairment, and normal cognitive function (DESK study): A multicenter, open-label, interventional study.
    Fukumoto T; Ezaki T; Urakami K
    eNeurologicalSci; 2022 Dec; 29():100439. PubMed ID: 36531966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
    Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease.
    Baldeiras I; Santana I; Leitão MJ; Vieira D; Duro D; Mroczko B; Kornhuber J; Lewczuk P
    Alzheimers Res Ther; 2019 Jan; 11(1):2. PubMed ID: 30611311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional study of retinal vessel changes based on optical coherence tomography angiography in Alzheimer's disease and mild cognitive impairment.
    Ma X; Xie Z; Wang H; Tian Z; Bi Y; Li Y; Zhang L
    Front Aging Neurosci; 2023; 15():1101950. PubMed ID: 37113575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring Network Properties Across Preclinical Stages of Alzheimer's Disease Using a Visual Short-Term Memory and Attention Task with High-Density Electroencephalography: A Brain-Connectome Neurophysiological Study.
    Lazarou I; Georgiadis K; Nikolopoulos S; Oikonomou VP; Stavropoulos TG; Tsolaki A; Kompatsiaris I; Tsolaki M;
    J Alzheimers Dis; 2022; 87(2):643-664. PubMed ID: 35367964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
    Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
    Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory memory in mild cognitive impairment and Alzheimer's disease.
    Audronyte E; Sutnikiene V; Pakulaite-Kazliene G; Kaubrys G
    Front Neurol; 2023; 14():1165594. PubMed ID: 37332995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Performance of an Eye-Tracking Assisted Visual Inference Language Test in the Assessment of Cognitive Decline due to Alzheimer's Disease.
    Belan AFR; Pais MV; Camargo MVZA; Sant'Ana LCFG; Radanovic M; Forlenza OV
    J Alzheimers Dis; 2023; 94(3):1105-1119. PubMed ID: 37355905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
    Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
    Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric Symptoms in Mild Cognitive Impairment and Dementia Due to AD: Relation With Disease Stage and Cognitive Deficits.
    Wiels WA; Wittens MMJ; Zeeuws D; Baeken C; Engelborghs S
    Front Psychiatry; 2021; 12():707580. PubMed ID: 34483998
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychometric Properties of Alzheimer's Disease Assessment Scale-Cognitive Subscale for Mild Cognitive Impairment and Mild Alzheimer's Disease Patients in an Asian Context.
    Zainal NH; Silva E; Lim LL; Kandiah N
    Ann Acad Med Singap; 2016 Jul; 45(7):273-83. PubMed ID: 27523508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relations of neuropsychiatric symptoms with disease stage, sex, and daily function in mild cognitive impairment and dementia due to Alzheimer's disease: A cross-sectional study.
    Zhang W; Wang X; Lü Y; Yu W
    J Psychosom Res; 2022 Oct; 161():110994. PubMed ID: 35939891
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.